Skip to content

Early recognition and management of maternal sepsis in Pakistan

Evaluation of the FAST-M maternal sepsis bundle in Pakistan: a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17105658
Enrollment
398
Registered
2021-11-04
Start date
2020-10-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal sepsis Pregnancy and Childbirth

Interventions

The study will be conducted in two phases. In the first phase (qualitative) the researchers will adapt the FAST-M bundle care tools for the local context. In the second phase, they will evaluate the f

Sponsors

Liaquat University of Medical & Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women who are pregnant or within 6 weeks of miscarriage, termination of pregnancy or delivery 2. Receiving inpatient health care

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Collected using CRFs every 2 weeks throughout the intervention phase: 1. The proportion of patients admitted with features of sepsis who received appropriate monitoring (full set of vital sign measurements on admission recorded on MEOWS chart) 2. The proportion of women with suspected maternal sepsis received antibiotics within 1 hour (if required) 3. The proportion of women with suspected maternal sepsis receiving the FAST-M treatment bundle (including each bundle component) within 1 hour of identification of sepsis 4. One focus group will be conducted before the initiation of the study to adapt the tools and identify implementation approaches 5. A second focus group will be conducted at the end of the study as a summative evaluation of the study to identify perceptions about the success of implementation

Secondary

MeasureTime frame
Collected using CRFs every 2 weeks throughout the intervention phase: 1. The proportion of women with suspected maternal sepsis referred to clinical decision-maker on the basis of abnormal vital signs records 2. The proportion of women with suspected maternal sepsis receiving a clinical review by a senior clinical decision-maker following their diagnosis

Countries

Pakistan

Contacts

Public ContactSheikh Irfan;Lumaan Ahmed;Sheikh

;

sheikh.irfan@aku.edu;lumaan.sheikh@aku.edu+92 (0)21 1234 4644;+92 (0)21 1234 4641

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026